US paediatric oncologists are forced to prioritise patients for vincristine treatment as supplies run short
Vincristine, a cornerstone of paediatric cancer treatment, is in critically short supply across the United States after one of the last two makers on the US market, Teva Pharmaceutical Industries,…
